A vaccine to prevent exacerbations in COPD

Robert L Clancy and Margaret Dunkley
Med J Aust 2011; 195 (2): . || doi: 10.5694/j.1326-5377.2011.tb03224.x
Published online: 18 July 2011

To the Editor: Animal and human studies confirm the view that colonisation by non-typeable Haemophilus influenzae (NTHi) of airways already damaged by inhaled toxins initiates a second major pathway of damage in chronic obstructive pulmonary disease (COPD). This provides a framework for novel and effective management strategies for this condition, which has previously been considered to be a self-induced disease of elderly people for which nothing can be done.1

  • Robert L Clancy1
  • Margaret Dunkley2

  • 1 Department of Immunology, Hunter Area Pathology Service, Newcastle, NSW.
  • 2 Biological Sciences and Pharmacy, University of Newcastle, Newcastle, NSW.

Competing interests:

Both authors are employed by the company working on the vaccine technology described in this letter and hold stock or stock options in the company.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.